Nanobiotix and Thomas Jefferson University Start Research Collaboration  
5/2/2012 10:23:31 AM

PARIS & PHILADELPHIA--(BUSINESS WIRE)--Nanobiotix, a company developing novel cancer nanotherapeutics and Thomas Jefferson University, one of Philadelphia's premier medical and health sciences universities, today announced that they have entered into a research collaboration to accelerate the development of Nanobiotix’ lead compound NBTXR3 in the US.